|
|
|
|
|
|
|
|
|
MSDS   | : | 7,14-Methano-2H,6H-dipyrido(1,2-a1',2'-e)(1,5)diazoc
in-6-one, dodecahydro-, monohydrochloride,
(7R-(7-alpha,7a-alpha,14-alpha,14a-beta))-
| CAS   | : | 40136-09-2 | SYNONYMS   | : | * 17-Oxosparteine hydrochloride
* Oxysparteine hydrochloride
|
| |
|
|
|
|
*** CHEMICAL IDENTIFICATION ***
RTECS NUMBER : PB9266500
CHEMICAL NAME : 7,14-Methano-2H,6H-dipyrido(1,2-a:1',2'-e)(1,5)diazoc
in-6-one, dodecahydro-, monohydrochloride,
(7R-(7-alpha,7a-alpha,14-alpha,14a-beta))-
CAS REGISTRY NUMBER : 40136-09-2
LAST UPDATED : 198706
DATA ITEMS CITED : 2
MOLECULAR FORMULA : C15-H24-N2-O.Cl-H
MOLECULAR WEIGHT : 284.87
SYNONYMS/TRADE NAMES :
* 17-Oxosparteine hydrochloride
* Oxysparteine hydrochloride
*** HEALTH HAZARD DATA ***
** ACUTE TOXICITY DATA **
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Subcutaneous
SPECIES OBSERVED : Rodent - rabbit
DOSE/DURATION : 600 mg/kg
TOXIC EFFECTS :
Behavioral - tremor
Cardiac - pulse rate
Lungs, Thorax, or Respiration - respiratory stimulation
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 27,431,1926
TYPE OF TEST : LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE : Parenteral
SPECIES OBSERVED : Amphibian - frog
DOSE/DURATION : 2 gm/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - mydriasis (pupillary dilation)
Behavioral - ataxia
Cardiac - pulse rate
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams &
Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10-
Volume(issue)/page/year: 27,431,1926
*** END OF RECORD ***
|
|
|
|
|
|
|
|
|
|
ALL Chemical Property And Toxicity Analysis PAGES IN THIS GROUP
| NAME | CAS |
7,14-Methano-2H,6H-dipyrido(1,2-a1',2'-e)(1,5)diazocine, dodecahydro-6-butyl-,(R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
| 75714-73-7 |
7,14-Methano-2H,6H-dipyrido(1,2-a1',2'-e)(1,5)diazocine, dodecahydro-, monohydriodide,(7R-(7-alpha,7a-alpha,14-alpha,14a-beta))-
| 51799-26-9 |
7,14-Methano-2H,6H-dipyrido(1,2-a1',2'-e)(1,5)diazocine, dodecahydro-6-pentyl-,(R-(R*,R*)-2,3-dihydroxybutanedioate (1:1)
| 75686-51-0 |
7,14-Methano-2H,6H-dipyrido(1,2-a1',2'-e)(1,5)diazocin-6-one, dodecahydro-, (7S-(7-alpha,7a-beta,14-alpha,14a-beta))-
| 82109-83-9 |
7,14-Methano-2H,6H-dipyrido(1,2-a1',2'-e)(1,5)diazocin-6-one, dodecahydro-, monohydrochloride,(7R-(7-alpha,7a-alpha,14-alpha,14a-beta))-
| 40136-09-2 |
Methane, fluorotrichloro- with nitromethane(99.7:0.3)SUBSTANCE DEFINITION :Contains 0.3% nitromethane in addition to freon-11REFERENCE :TOIZAG Toho Igakkai Zasshi. Journal of Medical Society of Toho University.(Toho Daigaku Igakkai, 21-16, Omori-nishi, 5-chome, Ota-ku, Tokyo 143,Japan) V.1- 1954-
| 40136-09-2 |
7,14-Methano-4H,6H-dipyrido(1,2-a1',2'-e)(1,5)diazocin-4-one, dodecahydro-, monohydrochloride,(7S-(7-alpha,7a-beta,14-alpha,14a-alpha))-
| 40136-09-2 |
5,11-Methanofuro(3,4-d)(3)benzoxonin-1,12(3H,5H)-dione, 6,6a,7,8,9,10,10a,11-octahydro-6,6a-dihydroxy-11,13-dimethyl-3-methylene-,(5R-(5R*,6S*,6aR*,10aR*,11S*,13R*))-
| 156980-57-3 |
5,11-Methanofuro(3,4-d)(3)benzoxonin-1,12(3H,5H)-dione, 6,6a,7,8,9,10,10a,11-octahydro-6,6a-dihydroxy-3,11,13-trimethyl-,(3R-(3R*,5R*,6S*,6ar*,10ar*,11S*,13R*))-
| 166403-10-7 |
1,24-Methano-1H,9H,15H-furo(3',4'10,11)(1,7)dioxacyclotetradecino(4,3-e)p yrano(2,3-i)(4)benzoxecin-6,13,15,18(3ah)-tetrone,4,5,7a,8,16,17,20,20a,24,25,26,26a-dodecahydro-8,26-dihydroxy-22,25-dimethyl-5-methoxy-
| 99820-21-0 |
1,5-Methano-11H-furo(3,2-g)pyrano(3,2-b)xanthene-3a(4H)-crotonaldehyde, 1,2,5,7-tetrahydro-8-hydroxy-alpha,2,2,11,11-pentamethyl-13-(3-methyl-2-butenyl)-4,7-dioxo-, trans-
| 1183-12-6 |
1,5-Methano-1H,3H,11H-furo(3,4-g)pyrano(3,2-b)xanthene-1-crotonic acid, 3a,4,5,7-tetrahydro-8-hydroxy-alpha,3,3,11-tetramethyl-13-(3-methyl-2-butenyl)-11-(4-methyl-3- pentenyl)-7,15- dioxo-, (Z)-
| 2752-65-0 |
8,12-Methano-2H-furo(3,2-g)pyrano(2,3-a)xanthene-10a(11H)-crotonic acid, 8,9,12,14-tetrahydro-5-hydroxy-alpha,2,9,9-tetramethyl-6-(3-methyl-2-butenyl)-2-(4-m ethyl-3- pentenyl)-11,14-dioxo-
| 6129-34-6 |
2,5-Methanoindan-4-amine, hexahydro-N-benzyl-,hydrochloride
| 59177-71-8 |
2,5-Methanoindan-4-amine,hexahydro-4-(p-chlorobenzyl)-, hydrochloride
| 67293-83-8 |
2,5-Methanoindan-4-amine, hexahydro-, hydrochloride
| 59177-69-4 |
Methane, fluorotrinitro-
| 1840-42-2 |
2,5-Methanoindan-4-amine,hexahydro-4-(2-hydroxyethyl)amino-, hydrochloride
| 59177-73-0 |
2,5-Methanoindan-4-amine, hexahydro-N-methyl-,hydrochloride
| 59177-70-7 |
2,5-Methanoindan-4-amine, hexahydro-4-phenethyl-,hydrochloride
| 67293-84-9 |
4,7-Metanoindan-2,5-bis(methylamine),hexahydro-N,N'-dicyclohexyl-, dihydrochloride
| 63905-06-6 |
4,7-Methanoindan, 1,25,6-diepoxyhexahydro-, mixedisomersSUBSTANCE DEFINITION :Mixture of 70% exo isomers, 30% endo isomersREFERENCE :AIHAAP American Industrial Hygiene Association Journal. (AIHA, 475 WolfLedges Pkwy., Akron, OH 44311) V.19- 1958-
| 63905-06-6 |
4,7-Methanoindan,1,4,5,6,7,8,8-heptachloro-2,3-epoxy-3a,4,7,7a-tetrahydro-
| 1024-57-3 |
4,7-Methanoindan,1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-
| 2589-15-3 |
4,7-Methanoindan, hexahydro-, exo-
| 2825-82-3 |
4,7-Methanoindan, hexahydro-1,8-diamino-
| 6818-18-4 |
4,7-Methanoindan,3a,4,5,6,7,7a-hexahydro-1,2:5,6-diepoxy-
| 81-21-0 |
Methanehydrazonamide,N'-(1,2-dihydro-2-oxo-3H-indol-3-ylidene)-N,N-dimethyl-
| 56364-22-8 |
4,7-Methanoindan,3a,4,5,6,7,7a-hexahydro-1,2:5,6-diepoxy-, endo-
| 56364-22-8 |
4,7-Methanoindan, hexahydro-2-hydroxymethyl-
| 64644-36-6 |
2,5-Methanoindan-4-methylamine, hexahydro-N-benzyl-,maleate
| 59177-78-5 |
2,5-Methanoindan-4-methylamine,hexahydro-N,N-dimethyl-4-hydroxy-, hydrochloride,hydrate (3:3:1)
| 67293-85-0 |
2,5-Methanoindan-4-methylamine,hexahydro-4-hydroxy-N-methyl-, maleate
| 59177-79-6 |
2,5-Methanoindan-4-methylamine, hexahydro-N-methyl-,maleate
| 59177-76-3 |
4,7-Methanoindan,1,2,4,5,6,7,8,8-octachloro-2,3-epoxy-3a,4,7,7a-tetrahydro-, exo,endo-
| 27304-13-8 |
4,7-Methanoindan,1-alpha,2-alpha,4-beta,5,6,7-beta,8,8-octachloro-3a-alpha,4,7,7a-alpha- tetrahydro-
| 5103-71-9 |
4,7-Methanoindan,1,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-
| 57-74-9 |
4,7-Methanoindan,2,2,4,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-,stereoisomer
| 5566-34-7 |
Methane, iodo-
| 74-88-4 |
4,7-Methanoindan,1,2,3,5,6,7,8,8-octachloro-3a,4,7,7a-tetrahydro-, (Z)mixed with E-1,2,3,5,6,7,8,8-octachloro-4,7-methano-3a,4,7,7a-tetrahydroindane (3:1)
| 74-88-4 |
2,5-Methanoindan-4-ol,hexahydro-4-(4-methyl-1-piperazinyl)methyl-,dihydrochloride
| 59177-82-1 |
4,7-Methanoindan-1-ol,3a,4,7,7a-tetrahydro-2,3-epoxy-4,5,6,7,8,8-hexachloro-
| 24009-06-1 |
4,7-Methanoindan-5(4H)-one, tetrahydro-
| 13380-94-4 |
4,7-Methanoindan,3a,4,7,7a-tetrahydro-1,2-epoxy-4,5,6,7,8,8-hexachloro-
| 6058-23-7 |
4,7-Methanoindan,3a-alpha,4,7,7a-alpha-tetrahydro-2-alpha,4-beta,5,6,7-beta,8,8-heptachloro-
| 14168-01-5 |
4,7-Methanoindan,3a-beta,4,7,7a-beta-tetrahydro-1-beta,2-alpha,4-alpha,5,6,7-alpha,8,8- octachloro-
| 5103-74-2 |
4,7-Methano-1H-inden-5-amine,octahydro-N-(cyclopropylmethyl)-, hydrochloride,(3a-alpha,4- beta,5-alpha,7-beta,7a-alpha)-
| 73336-07-9 |
4,7-Methanoindene
| 209-96-1 |
4,7-Methanoindene,1-bromo-4,5,6,7,8,8-hexachloro-3a,4,7,7a-tetrahydro-
| 3186-23-0 |
Methane, iodo-, pyrolyzate
| 3186-23-0 |
|
|
|
|